Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Real-life use of the eutectic mixture lidocaine/prilocaine spray in men with premature ejaculation

International Journal of Impotence Research volume 34, pages 289–294 (2022)Cite this article

Subjects

Abstract

Topical anaesthetics are considered a first-line therapy option in men with premature ejaculation (PE). A cross-sectional retrospective analysis was performed to evaluate the real-life use of the eutectic mixture of prilocaine/lidocaine spray (FORTACIN™) in a cohort of 198 white-European men who had been consecutively and prospectively seen at a single tertiary-referral andrology centre for self-reported PE and naive for previous PE treatments. Descriptive statistics was used to describe the whole cohort and the paired t-test was applied to investigate potential differences throughout a 12-month follow-up (baseline, 1, 3, 6 and 12 months). Overall, mean (SD) age was 37 (6.5) years. Of all, lifelong, acquired and subjective PE were reported in 101 (51%), 59 (29.8%) and 38 (19.2%) patients at baseline, respectively. FORTACIN™ use increased up to 6 months, with 184 (92.9%) and 128 (66.4%) men who had tried and regularly used the compound, respectively. At 12-month follow-up, 53 (26.8%) men reported a regular use of the compound. Mean Premature Ejaculation Diagnostic Tool score significantly decreased at 6 and 12 months compared to baseline (all p < 0.05). Conversely, mean IELT significantly improved at 6-month follow-up compared to baseline (all p ≤ 0.04). Overall, FORTACIN™ emerged to be a safe and effective treatment option in PE patients of various types, with almost one fourth of patients still under treatment after 12 months. Timing and dosing of the drug can deserve to be adjusted according to patient’s needs and their sexual ecology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, et al. EAU guidelines on sexual and reproductive health. Available from: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Sexual-and-Reproductive-Health-2020.pdf. Assessed 5 April 2020.

  2. McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13:144–52. https://doi.org/10.1016/j.jsxm.2015.12.034.

    Article  PubMed  Google Scholar 

  3. Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14:1557988320937200. https://doi.org/10.1177/1557988320937200.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423–41. https://doi.org/10.1111/jsm.12524.

    Article  PubMed  Google Scholar 

  5. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II−proposals for DSM-V and ICD-11. J Sex Med. 2006;3:693–705. https://doi.org/10.1111/j.1743-6109.2006.00276.x.

    Article  PubMed  Google Scholar 

  6. Castiglione F, Albersen M, Hedlund P, Gratzke C, Salonia A, Giuliano F. Current pharmacological management of premature ejaculation: a systematic review and meta-analysis. Eur Urol. 2016;69:904–16. https://doi.org/10.1016/j.eururo.2015.12.028.

    Article  CAS  PubMed  Google Scholar 

  7. EMA. FORTACINTM: summary of product characteristics. 2014.

  8. Dinsmore WW, Wyllie MG. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int. 2009;103:940–9. https://doi.org/10.1111/j.1464-410X.2009.08456.x.

    Article  CAS  PubMed  Google Scholar 

  9. Carson C, Wyllie M. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase iii, double-blind, placebo-controlled study. J Sex Med. 2010;7:3179–89. https://doi.org/10.1111/j.1743-6109.2010.01913.x.

    Article  CAS  PubMed  Google Scholar 

  10. Porst H, Burri A. Novel treatment for premature ejaculation in the light of currently used therapies: a review. Sex Med Rev. 2019;7:129–40. https://doi.org/10.1016/j.sxmr.2018.05.001.

    Article  PubMed  Google Scholar 

  11. Fusco F, Creta M, Mangiapia F, Cirigliano L, Trama F, Pandolfo SD, et al. Perceptions, expectations, preferences, and attitudes toward premature ejaculation, its diagnosis and topical treatment with Fortacin™ spray: results from an expert panel discussion. Res Rep. Urol. 2020;12:211–6. https://doi.org/10.2147/RRU.S250301.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  Google Scholar 

  13. Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, et al. Development and validation of a Premature Ejaculation Diagnostic Tool. Eur Urol. 2007;52:565–73. https://doi.org/10.1016/j.eururo.2007.01.028.

    Article  PubMed  Google Scholar 

  14. Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol. 2007;177:1059–64. https://doi.org/10.1016/j.juro.2006.10.044. discussion 1064

    Article  PubMed  Google Scholar 

  15. Pozzi E, Capogrosso P, Boeri L, Cazzaniga W, Matloob R, Ventimiglia E, et al. Trends in reported male sexual dysfunction over the past decade: an evolving landscape. Int J Impot Res. 2020. https://doi.org/10.1038/s41443-020-0324-7.

  16. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816–23. https://doi.org/10.1016/j.eururo.2006.07.004. discussion 824

    Article  PubMed  Google Scholar 

  17. Georgiadis JR, Simone Reinders AaT, Van der Graaf FHCE, Paans AMJ, Kortekaas R. Brain activation during human male ejaculation revisited. NeuroReport. 2007;18:553–7. https://doi.org/10.1097/WNR.0b013e3280b10bfe.

    Article  PubMed  Google Scholar 

  18. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998;92:111–8. https://doi.org/10.1016/s0166-4328(97)00183-6.

    Article  CAS  PubMed  Google Scholar 

  19. Park HJ, Park NC, Kim TN, Baek SR, Lee KM, Choe S. Discontinuation of dapoxetine treatment in patients with premature ejaculation: a 2-year prospective observational study. Sex Med. 2017;5:e99–105. https://doi.org/10.1016/j.esxm.2017.02.003.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jenkins LC, Gonzalez J, Tal R, Guhring P, Parker M, Mulhall JP. Compliance with fluoxetine use in men with primary premature ejaculation. J Sex Med. 2019;16:1895–9. https://doi.org/10.1016/j.jsxm.2019.09.017.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Salonia A, Rocchini L, Sacca’ A, Pellucchi F, Ferrari M, Carro UD, et al. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. J Sex Med. 2009;6:2868–77. https://doi.org/10.1111/j.1743-6109.2009.01404.x.

    Article  CAS  PubMed  Google Scholar 

  22. Liu H, Zhang M, Huang M, Cai H, Zhang Y, Liu G, et al. Comparative efficacy and safety of drug treatment for premature ejaculation: A systemic review and Bayesian network meta-analysis. Andrologia. 2020;52:e13806 https://doi.org/10.1111/and.13806.

    Article  CAS  PubMed  Google Scholar 

  23. Ditto KE. SSRI discontinuation syndrome. Awareness as an approach to prevention. Postgrad Med. 2003;114:79–84. https://doi.org/10.3810/pgm.2003.08.1474.

    Article  PubMed  Google Scholar 

  24. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci JPN. 2000;25:255–61.

    CAS  PubMed  Google Scholar 

  25. Russo A, Capogrosso P, Ventimiglia E, La Croce G, Boeri L, Montorsi F, et al. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review. Int J Clin Pr. 2016;70:723–33. https://doi.org/10.1111/ijcp.12843.

    Article  CAS  Google Scholar 

  26. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a "Waterloo" . Urology. 1AD;82. https://doi.org/10.1016/j.urology.2013.05.018.

  27. Salonia A, Saccà A, Briganti A, Del Carro U, Dehò F, Zanni G, et al. Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study. J Sex Med. 2009;6:1755–62. https://doi.org/10.1111/j.1743-6109.2009.01276.x.

    Article  PubMed  Google Scholar 

  28. Porst H, Burri A. FortacinTM spray for the treatment of premature ejaculation. Urologia. 2017;84:1–10. https://doi.org/10.5301/uj.5000275.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wyllie MG, Powell JA. The role of local anaesthetics in premature ejaculation. BJU Int. 2012;110:E943–948. https://doi.org/10.1111/j.1464-410X.2012.11323.x.

    Article  CAS  PubMed  Google Scholar 

  30. Alghobary M, Gaballah M, El-Kamel MF, State AF, Ismail SR, Selim MK, et al. Oral dapoxetine versus topical lidocaine as on-demand treatment for lifelong premature ejaculation: a randomised controlled trial. Andrologia. 2020;52:e13558 https://doi.org/10.1111/and.13558.

    Article  PubMed  Google Scholar 

  31. Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, et al. Further evidence of the reliability and validity of the Premature Ejaculation Diagnostic Tool. Int J Impot Res. 2007;19:521–5. https://doi.org/10.1038/sj.ijir.3901567.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy

    Luca Boeri, Edoardo Pozzi, Giuseppe Fallara, Francesco Montorsi & Andrea Salonia

  2. Department of Urology, Foundation IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

    Luca Boeri

  3. University Vita-Salute San Raffaele, Milan, Italy

    Edoardo Pozzi, Giuseppe Fallara, Francesco Montorsi & Andrea Salonia

Authors
  1. Luca Boeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edoardo Pozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Fallara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Montorsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrea Salonia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Salonia.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boeri, L., Pozzi, E., Fallara, G. et al. Real-life use of the eutectic mixture lidocaine/prilocaine spray in men with premature ejaculation. Int J Impot Res 34, 289–294 (2022). https://doi.org/10.1038/s41443-021-00424-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-021-00424-9

This article is cited by

Search

Advanced search

Quick links